NCT07197099 Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
| NCT ID | NCT07197099 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Azhar University |
| Condition | Neurological Autoimmune Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-01-01 with a primary completion date of 2025-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.
Eligibility Criteria
Inclusion Criteria: * 1\. All neurological patients irrespective of age who will undergo TPE. 2.All new and relapse cases that meet the ASFA guidelines and where TPE is the first and/or second line of therapy Exclusion Criteria: * 1\. Individuals with contraindications to therapeutic plasma exchange, such as hemodynamic unstable, hypocalcaemia, allergy to fresh frozen plasma or albumin. 2.Patients who will undergo fewer than five cycles of TPE and not complete the procedure. 3.Patients with non-neurological disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07197099 clinical trial?
This trial is open to participants of all sexes, studying Neurological Autoimmune Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07197099 currently recruiting?
Yes, NCT07197099 is actively recruiting participants. Contact the research team at wajdyessa91@gmail.com for enrollment information.
Where is the NCT07197099 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07197099 clinical trial?
NCT07197099 is sponsored by Al-Azhar University. The trial plans to enroll 60 participants.